Overview
- 8 inspections across 8 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-07-17.
At a glance
Inspections
8
Sites
8
Observations
24
Career since
Oct 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 17 Jul 2025 | Human Drugs | |
| Cardinal Health 414, Inc. | 13 Jun 2025 | Human Drugs | On file |
| Northwest Cosmetic Laboratories LLC | 3 Jun 2025 | Human Drugs | On file |
| Rigel Pharmaceuticals, Inc. | 28 Mar 2025 | Human Drugs | |
| Infinity Labs SD, Inc | 25 Mar 2025 | Human Drugs | On file |
Sites inspected
Ultragenyx Pharmaceutical Inc.Novato, United States1 insp.
Cardinal Health 414, Inc.Seattle, United States1 insp.
Northwest Cosmetic Laboratories LLCIdaho Falls, United States1 insp.
Rigel Pharmaceuticals, Inc.South San Francisco, United States1 insp.
Infinity Labs SD, IncPetaluma, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Darren S Brown2 shared
Christopher R Czajka2 shared
Carolina D Vasquez1 shared
Navneet Kaur1 shared
Lena Nguyen1 shared
Cecilia H Kieu1 shared
Claudia M Perez-Kasmarski1 shared
Michael Araneta1 shared
Full investigator report
Get the verbatim findings behind Jason K Loo's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site